Chemical Entities of Biological Interest
100047 terms(s) returned
| Term Type: | Record: 1 to 50 of 100047 Records | Page: 1 of 2001, First Previous Next Last | Show Records Per Page |
- ((13)C5,(15)N)-valine
- ((1R,2R,5R)-2-(2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl)-7,7-dimethyl-4-bicyclo(3.1.1)hept-3-enyl) methanol
- ((1aR,2S,2aR,7aR)-1a,2a,6,6-tetramethyl-7-oxodecahydronaphtho[2,3-b]oxiren-2-yl)methyl palmitate
- ((4R)-4-((3R,5R,9S,10S,12R,13R,14S,17R)-3,12-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-aspartic acid
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)tyrosine
- ((4R)-4-((3R,5S,7R,9S,10S,12S,13R,14S,17R)-3,7,12-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)valine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2,2-dimethylpentanoyl)glycine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-D-phenylalanine
- ((4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-Dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)-L-phenylalanine
- ((6Z)-Adda3)Nodularin
- ((R)-3-Hydroxybutanoyl)(n-2)
- ((R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pent-2-enoyl)glycine
- (+)-(10E,15R)-12-hydroxy-10,11-dehydrocurvularin
- (+)-(10R)-7-hydroxy-3-(2-hydroxypropyl)-5,6-dimethylisochromen-1-one
- (+)-(11R,2'S)-erythro-mefloquine
- (+)-(12E,2S,3S,4R,5R,6R,9S,11S,15R)-3-benzoyloxy-5,6-epoxylathyr-12-en-15-ol-14-one
- (+)-(12E,2S,3S,4R,5R,6R,9S,11S,15R)-3-cinnamoyloxy-5,6-epoxylathyr-12-en-15-ol-14-one
- (+)-(12E,2S,3S,4R,5R,9S,11S,15R)-15-cinnamoyloxy-lathyra-6(17),12-diene-3,5-diol-14-one
- (+)-(1R)-1,12-dihydroxy-20-norabieta-5(10),8,11,13-tetraene
- (+)-(1R)-1-[4-(4-fluorophenyl)-2,6-diisopropyl-5-propylpyridin-3-yl]ethanol
- (+)-(1R,3R,6S,7S,11R)-3,12-dihydroxy-alpha-muurolene
- (+)-(1R,3R,6S,7S,11S)-3,12-dihydroxy-alpha-muurolene
- (+)-(1R,3R,6S,7S,8R,11S)-3,8,12-trihydroxy-alpha-muurolene
- (+)-(1R,5R,6R,7R,10R)-cadinan-4(11)-ene-1,5,12-triol
- (+)-(1R,5R,6R,7S,10R)-cadinan-3-ene-1,5-diol
- (+)-(1R,6S,7S)-tremul-2-ene-12(11)-lactone
- (+)-(1S,2S)-norcoronamic acid
- (+)-(2S,3R,9R)-pristinol
- (+)-(2S,3S,4aS)-altenuene-3-acetoxy ester
- (+)-(3R)-1,7-bis(4-hydroxyphenyl)-(6E)-6-hepten-3-ol
- (+)-(3R)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-(6E)-6-hepten-3-ol
- (+)-(3R)-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptan-3-ol
- (+)-(3R)-1-(3,4-dihydroxyphenyl)-7-phenyl-(6E)-6-hepten-3-ol
- (+)-(3R)-3-acetoxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)-(6E)-6-heptene
- (+)-(3R)-3-acetoxy-1-(3,4-dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane
- (+)-(3S,6R,7R,10S)-tremul-1-ene-6,10,12-triol
- (+)-(3S,6S,7R,8S)-periconone A
- (+)-(4R,8R)-foedanolide
- (+)-(5E,12E,2S,3S,4S,9S,11S,15R)-3-cinnamoyloxylathyra-5,12-dien-15-ol-14-one
- (+)-(5S)-12-hydroxy-2-oxo-20-norabieta-1(10),8,11,13-tetraene
- (+)-(5S,6S,10R)-12-hydroxy-7-oxo-abieta-8,11,13-trien-20-oic acid6,20-lactone
- (+)-(5S,6S,7R,10R)-6,7,12-trihydroxyabieta-8,11,13-trien-20-oic acid 6,20-lactone
- (+)-(5S,6S,7S,8R,10R)-6-hydroxy-7,8-epoxy-12-oxo-abieta-9(11),13-dien-20-oic acid 6,20-lactone
- (+)-(5S,7R)-7-ethoxy-12-hydroxy-2-oxo-20-norabieta-1(10),8,11,13-tetraene
- (+)-(5alpha,23E)-27-nor-lanosta-8,23-dien-3,7,25-trione
- (+)-(5alpha,23R,24Z)-lanosta-8,24-dien-3,7-dioxo-23,26-gamma-lactone
- (+)-(5alpha,24E)-15alpha-hydroxylanosta-7,9(11),24-trien-3-oxo-26-AL
- (+)-(5alpha,24E)-3beta,11alpha-dihydroxylanosta-8,24-dien-7-oxo-26-AL
